← naar grote beleggers
Novo Holdings A/S
vermogensbeheerder · portefeuille $1.72 mld. · 25 posities · rapport per 30.06.2026
Aandelenposities rapport over 30.06.2026, ingediend op 14.08.2026; verandering — t.o.v. 31.03.2026 · 28
| Bedrijf | Aandelen | Waarde | % van de portefeuille | Verandering per kwartaal |
|---|---|---|---|---|
| Edgewise Therapeutics Inc US:EWTX | 5 350 000 | $217 mln. | 12.62% | — |
| ASML HOLDING N V CUSIP N07059210 | 94 946 | $189 mln. | 10.97% | — |
| Hemab Therapeutics Holdings,… US:COAG | 4 180 550 | $154 mln. | 8.92% | nieuw |
| Brookfield Corporation US:BN | 3 496 245 | $150 mln. | 8.68% | — |
| MapLight Therapeutics, Inc. US:MPLT | 3 686 622 | $132 mln. | 7.67% | — |
| Mirum Pharmaceuticals Inc US:MIRM | 1 125 000 | $132 mln. | 7.65% | −200 000 |
| Avalyn Pharma Inc. US:AVLN | 3 883 289 | $128 mln. | 7.42% | nieuw |
| Salesforce.com Inc US:CRM | 393 187 | $61.6 mln. | 3.58% | — |
| ArriVent BioPharma, Inc. US:AVBP | 1 500 000 | $52.1 mln. | 3.03% | −442 142 |
| Enliven Therapeutics Inc. US:ELVN | 1 000 000 | $50.8 mln. | 2.95% | −280 000 |
| CRINETICS PHARMACEUTICALS IN CUSIP 22663K107 | 1 320 000 | $49.4 mln. | 2.87% | −230 000 |
| PHARVARIS N V CUSIP N69605108 | 1 400 000 | $48.4 mln. | 2.81% | −350 000 |
| Floor & Decor Holdings Inc US:FND | 797 000 | $47.3 mln. | 2.75% | nieuw |
| Vaxcyte Inc US:PCVX | 800 000 | $46.5 mln. | 2.70% | −60 000 |
| 4D Molecular Therapeutics In… US:FDMT | 3 249 178 | $43.2 mln. | 2.51% | −401 559 |
| Viridian Therapeutics Inc US:VRDN | 2 135 000 | $39.2 mln. | 2.28% | +135 000 |
| Celldex Therapeutics Inc US:CLDX | 1 025 000 | $38.1 mln. | 2.21% | −175 000 |
| Alumis Inc US:ALMS | 1 100 000 | $31.0 mln. | 1.80% | nieuw |
| Xenon Pharmaceuticals Inc US:XENE | 485 438 | $29.3 mln. | 1.70% | — |
| Alibaba Group Holding Limite… US:BABA | 257 327 | $24.7 mln. | 1.43% | — |
| Dyne Therapeutics Inc US:DYN | 960 394 | $21.3 mln. | 1.24% | nieuw |
| BridgeBio Oncology Therapeut… US:BBOT | 2 250 000 | $17.1 mln. | 1.00% | +64 077 |
| Insmed Inc US:INSM | 120 723 | $12.9 mln. | 0.75% | nieuw |
| MARQETA INC CUSIP 57142B104 | 441 558 | $7.17 mln. | 0.42% | — |
| LanzaTech Global Inc. US:LNZA | 158 148 | $1.08 mln. | 0.06% | — |
| APOGEE THERAPEUTICS INC CUSIP 03770N101 | 0 (was 450 000) | — | — | verkocht |
| Biomarin Pharmaceutical Inc US:BMRN | 0 (was 660 000) | — | — | verkocht |
| Valneva SE US:VALN | 0 (was 1 057 421) | — | — | verkocht |
In bedrijven uit onze database 7
| Bedrijf | Belang | Aandelen | Rapportdatum |
|---|---|---|---|
| Hemab Therapeutics Holdings,… | 8.95% | 4 180 550 | 2026-06-30 |
| Avalyn Pharma Inc. | 8.76% | 3 883 289 | 2026-06-30 |
| MapLight Therapeutics, Inc. | 6.63% | 3 686 622 | 2026-06-30 |
| 4D Molecular Therapeutics In… | 5.88% | 3 249 178 | 2026-06-30 |
| Edgewise Therapeutics Inc | 4.93% | 5 350 000 | 2026-06-30 |
| BridgeBio Oncology Therapeut… | 2.81% | 2 250 000 | 2026-06-30 |
| LanzaTech Global Inc. | 1.21% | 158 148 | 2026-06-30 |
advertentie